EOC Pharma Group
https://www.eocpharma.com/index.html
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From EOC Pharma Group
The Journey Has Just Begun For LAG-3 Therapeutics
Clinical stage innovator Immutep talks to In Vivo about the potential for LAG-3 antibodies in cancer and autoimmune diseases.
Aadi Starts Small With Fyarro, But Has Tumor-Agnostic Strategy In Mind
The approval of Fyarro marks the first for advanced malignant PEComa, a rare cancer that affects only 100-300 people in the US; it's also the first launch for Aadi Biosciences.
Asia Deal Watch: Takeda, KSQ Take CRISPR Approach To T-Cell Oncology Therapy
Plus deals involving Astellas/Actinium, Sosei/PharmEnable, Aadi/EOC Pharma, BeiGene/Strand, Chi-Med/Inmagene, Alteogen/Intas, Sosei/AbbVie, Y-Biologics/3D Medicines.
Baby-Wipes Maker Nutek Cites Contamination Risk In Nationwide Recall
Nutek withdraws a slew of baby-wipe brands sold through Walgreens, Family Dollar, Diapers.com and other retailers due to possible contamination with B. cepacia bacteria, a potentially serious infection threat to immunocompromised individuals and sufferers of cystic fibrosis in particular.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice